Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Vijay Pande
AddedMar 31, 2024
UpdatedMay 31, 2026
Vijay Pande

Vijay Pande

Board Member, Schrödinger

CrunchbaseLinkedIn

Vijay Pande's Career

Schrödinger
Schrödinger

New York City, NY, US

Board Member· Board
Q Bio
Q Bio

San Carlos, CA, US

Board Member· Board
Globavir Biosciences
Globavir Biosciences

Los Altos, CA, US

Co-Founder
BioAge Labs
BioAge Labs

Richmond, CA, US

Board Member· Board
Insitro
Insitro

South San Francisco, CA, US

Board Member· Board
Freenome
Freenome

South San Francisco, CA, US

Board Member· Board
Omada Health
Omada Health

San Francisco, CA, US

Board Member· Board
Devoted Health
Devoted Health

Waltham, MA, US

Board Member· Board
Apeel
Apeel

Goleta, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Vijay Pande's Career

Schrödinger
Schrödinger
Public$567.2M7871990New York City, NY, US
Board Member· Board

Leadership at Schrödinger

Richard A. FriesnerRichard A. FriesnerBoard Member
William L. JorgensenWilliam L. JorgensenBoard Member
Michael LyntonMichael LyntonBoard Member
Ramy FaridRamy FaridBoard Member
Jeffrey ChodakewitzJeffrey ChodakewitzBoard Member
Matthew P JacobsonMatthew P JacobsonBoard Member
Q Bio
Q Bio
Series B$64M502015San Carlos, CA, US
Board Member· Board

Leadership at Q Bio

Michael SnyderMichael SnyderCo-Founder
Jeffrey KaditzJeffrey KaditzCo-Founder
Garry ChoyGarry ChoyCo-Founder
Clarissa ShenClarissa ShenBoard Member

Similar to Q Bio

QuantivlyQuantivlyBoston, MA, USData Analyticsest. 2019QuantivlyBoston, MA, US · est. 2019

Data-driven decision tool empowering radiology through precise data analysis.

Pre-Seed · $2.1M12
Q BioMedQ BioMedNew York City, NY, USBiomedical Assetsest. 2013Q BioMedNew York City, NY, US · est. 2013

QBioMed Inc.: A dedicated biomedical development firm, accelerating and providing strategic resources.

Public · $48M9
ProbiusProbiusFremont, CA, USBiotech, Diagnosticsest. 2016ProbiusFremont, CA, US · est. 2016

ProbiusDx: A deep-tech firm providing diagnostic tech for blood monitoring.

Series B · $12.9M13
QbDVisionQbDVisionAustin, TX, USPlatform, Softwareest. 2016QbDVisionAustin, TX, US · est. 2016

QbDVision: A pioneering biopharma platform transforming fragmented data into process intelligence.

Series A · $17M45
Globavir Biosciences
Globavir Biosciences
Public$11.5M302013Los Altos, CA, US
Co-Founder

Leadership at Globavir Biosciences

Dr. Shalabh K. Gupta M.D.Dr. Shalabh K. Gupta M.D.Co-Founder
John RyanJohn RyanBoard Member
BioAge Labs
BioAge Labs
Series C$123.9M1752015Richmond, CA, US
Board Member· Board

Recent news

Ocean’s new app brings inbox triage, tasks, and invites to Gmail usersTechCrunch · 2025
BioAge Labs Provides Business UpdatesLifespan Research Institute · 2024
BioAge raises $170M to back Phase 2-ready obesity drugBioPharma Dive · 2024

Leadership at BioAge Labs

Jason ColomaJason ColomaBoard Member
Eric MorgenEric MorgenCo-Founder
Rekha HemrajaniRekha HemrajaniBoard Member
Kristen FortneyKristen FortneyBoard Member

Similar to BioAge Labs

Generation LabGeneration LabSan Francisco, CA, USHealth SoftwareGeneration LabSan Francisco, CA, US

San Francisco-based Generation Lab develops software for biological age and disease risk assessment, promoting healthier lives.

Pre-Seed50
Regenerative BioRegenerative BioCambridge, MA, USPharmaceuticalsest. 2020Regenerative BioCambridge, MA, US · est. 2020

Regenerative Bio: AI-driven biotech firm pioneering anti-aging solutions through pharmaceutical tech.

Angel · $10M13
Rejuveron Life SciencesRejuveron Life SciencesSchlieren, Zürich, CHDrug Development, Therapiesest. 2019Rejuveron Life SciencesSchlieren, Zürich, CH · est. 2019

Rejuveron Life Sciences: A biotech platform investing in innovative therapies for healthy aging.

Late Stage Private · $97.6M22
Spring DiscoverySpring DiscoverySan Carlos, CA, USDrug Discovery, Therapeuticsest. 2017Spring DiscoverySan Carlos, CA, US · est. 2017

Spring Discovery: Accelerating therapy discovery for aging diseases via machine learning.

Series B · $22.3M29
Insitro
Insitro
Series C$643M2952018South San Francisco, CA, US
Board Member· Board

Leadership at Insitro

Roger PerlmutterRoger PerlmutterBoard Member
Daphne KollerDaphne KollerCEO
Daphne KollerDaphne KollerCEO
Robert NelsenRobert NelsenBoard Member
Paul McCrackenPaul McCrackenBoard Member
Freenome
Freenome
Late Stage Private$1.1B3752014South San Francisco, CA, US
Board Member· Board

Recent news

Vijay Pande, founding partner of a16z bio and health strategy, steps downTechCrunch · 2025

Leadership at Freenome

Gabriel OtteGabriel OtteCo-Founder
Mike NolanMike NolanCEO
Michael OtteMichael OtteCo-Founder
Riley EnnisRiley EnnisCo-Founder
Randy ScottRandy ScottBoard Member

Similar to Freenome

GRAILGRAILMenlo Park, CA, USCancer Detectionest. 2016GRAILMenlo Park, CA, US · est. 2016

GRAIL, Inc., a Menlo Park-based biotech firm, specializes in early cancer detection using science and technology.

Public · $2B823
EpinomaEpinomaSan Francisco, CA, USCancer Diagnosticsest. 2020EpinomaSan Francisco, CA, US · est. 2020

Innovative diagnostics company using multi-omics for cancer monitoring. Founded in 2020, based in San Francisco.

Pre-Seed · $125k6
OncodeaOncodeaSaint Paul, MN, USCancer Detectionest. 2021OncodeaSaint Paul, MN, US · est. 2021

Oncodea: Pioneering affordable, non-invasive cancer detection technology since 2021.

Angel · $6k7
Guardant HealthGuardant HealthPalo Alto, CA, USCancer Diagnosticsest. 2011Guardant HealthPalo Alto, CA, US · est. 2011

Guardant Health: A Palo Alto-based biotech firm providing global cancer diagnostics and sequencing services.

Public1.8k
Omada Health
Omada Health
Series D$528.5M7752011San Francisco, CA, US
Board Member· Board

Leadership at Omada Health

Sean DuffySean DuffyCo-Founder
Casper de ClercqCasper de ClercqBoard Member
Jonathan RootJonathan RootBoard Member
Andrew DiMicheleAndrew DiMicheleCo-Founder
Jeri HillemanJeri HillemanBoard Member
Adrian JamesAdrian JamesCo-Founder

Similar to Omada Health

BoldBoldSan Mateo, CA, USFitness Programsest. 2020BoldSan Mateo, CA, US · est. 2020

Bold is a digital health platform for older adults covered by Medicare Advantage plans.

Series A · $27M9
Vida HealthVida HealthSan Francisco, CA, USHealth Coaching, Virtual Careest. 2014Vida HealthSan Francisco, CA, US · est. 2014

Vida Health, Inc.: A virtual care app connecting patients with health professionals for live coaching.

Series B · $216.5M572
Cecelia HealthCecelia HealthNew York City, NY, USHealth Managementest. 2009Cecelia HealthNew York City, NY, US · est. 2009

Cecelia Health: A tech-enabled company transforming lives of those with diabetes and chronic diseases.

Series B · $22.4M317
Virta HealthVirta HealthSan Francisco, CA, USDiabetes Care, Weight Lossest. 2014Virta HealthSan Francisco, CA, US · est. 2014

Virta Health: A US-based healthcare center offering innovative, data-driven therapies for type two diabetes.

Series E · $373M375
Devoted Health
Devoted Health
Investment FirmInvestment Firm$2.1B1.5k2017Waltham, MA, US
Board Member· Board

Leadership at Devoted Health

Todd ParkTodd ParkBoard Member
Bob KocherBob KocherBoard Member
William FristWilliam FristBoard Member
Bryan RobertsBryan RobertsBoard Member
Kathleen SebeliusKathleen SebeliusBoard Member
Tabreez VerjeeTabreez VerjeeBoard Member
Apeel
Apeel
Late Stage Private$719.1M3372012Goleta, CA, US
Board Member· Board

Leadership at Apeel

Walter RobbWalter RobbBoard Member
Jason SpievakJason SpievakBoard Member
Ira EhrenpreisIra EhrenpreisBoard Member
James RogersJames RogersCEO

Similar to Apeel

GreenLifeTechGreenLifeTechBanner Elk, NC, USFood Preservationest. 2020GreenLifeTechBanner Elk, NC, US · est. 2020

GreenLifeTech™ develops cost-effective systems to extend fresh produce shelf life, reducing spoilage and waste.

Angel · $342.3k5
MoriMoriBoston, MA, USFood Preservationest. 2016MoriBoston, MA, US · est. 2016

Mori: All-natural food preservation solutions for longer-lasting freshness.

Series B · $82.3M110
AppertAppertOakland, CA, USFood Products, Ready Mealsest. 2020AppertOakland, CA, US · est. 2020

Revolutionizing food tech with high-pressure sterilization and vacuum sealing for year-long fresh storage.

Pre-Seed · $250k6
RipeLockerRipeLockerBainbridge Island, WA, USProduce Storageest. 2016RipeLockerBainbridge Island, WA, US · est. 2016

Agtech firm, RipeLocker, innovatively extends perishables' life using a unique, patent-pending system.

Series A · $25.8M18

Vijay Pande's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Vijay Pande

C. Tony LiuC. Tony LiuFounder · Reactive BiosciencesDavid HoDavid HoCo-Founder · RenBioGrace ZhaoGrace ZhaoCo-Founder · AccuraGenEnrique NavasEnrique NavasFounder · Q BioMedMartin Omid AkhavanMartin Omid AkhavanFounder · Anthro VenturesColin PovallColin PovallCo-Founder · Applied Biosciences